Boston Life Sciences, Greenwich Pharm in reverse acquisition Deal Date: Aug-01-1994 / Deal Update Date (Latest): Jan-01-1995 / Deal # 199410169 Executive Summary In a reverse merger, privately-held Boston Life Sciences (biotech targeting chronic diseases) will be acquired by publicly traded Greenwich Pharmaceuticals (cell adhesion molecules) and then essentially take over the business. Subscribers get more deal detail, updates, deal financials, deal products, and company information.
